Novel antisense transcript to pregnancy-associated plasma protein A

This target is a "novel transcript, antisense to PAPPA" (ENSG00000298257). It represents an RNA molecule transcribed from the DNA strand opposite to the PAPPA gene region, not encoding a protein, but potentially influencing the expression, processing, or stability of the PAPPA sense transcript[1][2][3][4]. Antisense transcription is widespread in eukaryotic genomes and can alter sense transcription dynamics—reducing rates of sense transcript production and processing, while potentially increasing transcript stability[1][2][3][4]. Its effects are often mediated via changes to the chromatin environment at or near the promoter of the sense gene and are considered a form of epigenetic regulation[1][2][3][4]. However, this specific "novel antisense transcript" is uncharacterized, and there is currently no evidence that it functions as a therapeutically actionable target, nor is it associated with drug interactions or disease phenotypes. The name and ID provided are largely descriptive, from genome annotation, and not aligned with established therapeutic target nomenclature. If later seeking structured information, note there may be insufficient curated functional or clinical data for this precise transcript; you would need to rely on general principles of antisense transcript function and mechanisms, as described in recent literature on antisense transcription and chromatin regulation[1][2][3][4].

Other names

ENSG00000298257Antisense transcript to PAPPAantisense RNA to pregnancy-associated plasma protein A